Livestock genetic engineering and precision breeding
Gene editing and genomic selection are converging on livestock breeding — from FDA-cleared heat-tolerant cattle and disease-resistant pigs to India's first gene-edited sheep.
1 · What it gives
Livestock genetic engineering combines CRISPR-Cas9 gene editing with genomic selection to accelerate traits that classical breeding reaches only after many generations. Porcine Reproductive and Respiratory Syndrome (PRRS) alone costs US pork producers an estimated $1.2 billion a year, and a single exon deletion in the CD163 receptor gene removes the virus’s entry point without adding any foreign DNA. The US FDA issued its first low-risk determination for an intentionally altered genomic DNA (IGA) in cattle on March 7, 2022, covering two PRLR-edited “SLICK” lines; by 2025–2026 the same low-risk framework had cleared a heat-tolerance edit and a PRRS-resistance edit for commercial use, while Canada’s food-safety regulators completed an independent review in parallel. Research groups outside the big three regulatory blocs are moving in parallel: India’s first gene-edited farm animal, a myostatin-pathway-edited sheep, took a single university team roughly six years and near 400 embryo- transfer trials to confirm.
Key directions of livestock genetic engineering:
- Disease-resistance editing (Disease-Resistance Gene Editing): single receptor-gene deletions (CD163 for PRRS) that block viral entry rather than boosting immunity, avoiding any transgene insertion.
- Thermotolerance editing (Thermotolerance Gene Editing): introducing naturally occurring heat-tolerance alleles (PRLR-SLICK) from tropically adapted cattle breeds into high-yield dairy and beef lines via CRISPR-Cas9.
- Genomic selection and sexed semen (Genomic Selection & Sexed Semen): SNP-chip genotyping of animals as young as ~6 months, paired with sex-sorted semen, that raises genetic gain without altering any genome.
- Public-sector founder-animal programs (Public-Sector Gene Editing): university and national-institute programs in India and China producing the first confirmed gene-edited founder animals in each country, ahead of any national commercial-approval pathway.
Sectoral value chain#
[trait discovery] ──> [edit design] ──> [founder production] ──> [regulatory review]
│
(risk-based
determination)
│
▼
[commercial herd] <─── [genomic selection] <─────────────────────────┘
Value chain levels#
| Level | Description | Key inputs/outputs |
|---|---|---|
| Trait Discovery | mining naturally occurring resistance/tolerance alleles | In: breed surveys, genome sequences. Out: candidate allele. |
| Edit Design | CRISPR-Cas9 construct targeting the candidate gene | In: guide RNA, donor template. Out: edit construct. |
| Founder Production | zygote injection or SCNT to derive edited founders | In: oocytes, edited cells. Out: founder embryos. |
| Regulatory Review | risk-based safety and food-consumption assessment | In: genotype/phenotype data. Out: low-risk determination. |
| Herd Multiplication | genomic selection expands the edited line | In: SNP genotyping, semen. Out: commercial breeding stock. |
| Commercial Deployment | supply-chain and processor acceptance | In: certified animals. Out: market-ready livestock. |
Cross-cutting technologies of the sector:
- CRISPR-Cas9 site-directed nucleases (CRISPR-Cas9 Site-Directed Nucleases): introduce single-base or short-exon edits that replicate existing natural alleles.
- Somatic cell nuclear transfer (Somatic Cell Nuclear Transfer): clones edited donor cells into enucleated oocytes to derive founder animals.
- SNP-chip genomic evaluation (SNP-Chip Genomic Evaluation): genome-wide marker panels that estimate breeding values without any gene editing.
2 · What it replaces 4 · matched by industry
3 · How to implement 6 steps
- 1Trait/allele discoveryBreed surveys identify a naturally occurring resistance or tolerance allele — the PRLR short-hair allele in Criollo cattle, or the CD163 receptor variant that blocks PRRS entry.
- 2Edit design & deliveryA CRISPR-Cas9 construct is designed to reproduce the natural allele, delivered by zygote microinjection or into a donor cell line for cloning.
- 3Founder confirmationEdited embryos are gestated to term and genotyped; SKUAST-Kashmir’s program needed close to 400 embryo transfers over six years to confirm one correctly edited lamb.
- 4Regulatory risk reviewRegulatory & certificationA risk-based agency review compares the edited genome against natural variation; the FDA’s first cattle determination took from initial submission to a March 7, 2022 low-risk clearance.Registration in Russia / EAEU: BREED — Ministry of Agriculture (breeding import permits) / Rosselkhoznadzor (GMO registration)
- 5Herd multiplicationSNP-chip genomic selection and sexed semen expand the edited line into a commercial-scale herd without further editing.
- 6Commercial deploymentRegulatory & certificationProcessor and export-market acceptance is confirmed; as of 2026 no major US milk processor had yet committed to a branded price premium for gene-edited-line milk, even after full regulatory clearance.Registration in Russia / EAEU: BREED — Ministry of Agriculture (breeding import permits) / Rosselkhoznadzor (GMO registration)
4 · Who delivers
Matched suppliers (matched automatically)
| Acceligen | United States | Not classified | active |
| Semex | Canada | Distributor | active |
| Inari Agriculture | United States | Producer | active |
| Genus | United Kingdom | Distributor | active |
| DBN Group 大北农 (SZ 002385) | China | Research / RTO | active |
| BioConsortia | United States | Producer | active |
| Volcani Institute (Agricultural Research Organization) | Israel | Research / RTO | active |
| Sanatech Seed | Japan | Research / RTO | active |
In the services and supply catalogue 1 · paid service
Leading companies and institutes (from the brief)
| Company / Institute | Country | Key products / platforms | Tech features | Status 2026 |
|---|---|---|---|---|
| Acceligen | 🇺🇸 USA | PRLR-SLICK cattle | FDA low-risk determination (Mar 2022); CRISPR PRLR heat-tolerance edit | Commercial |
| Genus plc / PIC | 🇬🇧 UK | PRRS-Resistant Pig | CD163 exon deletion; FDA-approved Apr 2025, Health Canada/CFIA Jan 2026 | Commercial |
| Semex | 🇨🇦 Canada | Genomic selection & sexed-semen programs | SNP-chip genomic evaluation, sex-sorted semen | Commercial |
| SKUAST-Kashmir | 🇮🇳 India | India’s first gene-edited sheep | Myostatin-pathway muscle edit; ~400 embryo-transfer trials over 6 years | Research |
| Inner Mongolia Agricultural University | 🇨🇳 China | CRISPR PRLR dairy-cattle embryos | SCNT-based PRLR exon editing for heat tolerance | Research |
5 · Rules & route to market
import permit within 30 working days (conventional genetics); gene-edited animals: GMO registration
Information, not legal advice — confirm the procedure for your product. (2026-10-06)
United States
The US holds the lead regulatory pathway: the FDA’s risk-based framework for intentionally altered genomic DNA in animals has cleared both a thermotolerance and a disease-resistance edit for the food supply.
FDA low-risk determinations, IGA guidance, genomic-selection adoption#
- FDA Guidance for Industry #187: the risk-based review track that classifies genomic alterations mirroring natural alleles as low-risk rather than requiring a full new-animal-drug approval.
- Acceligen PRLR-SLICK determination (March 7, 2022): the first FDA low-risk clearance for a gene-edited cattle line, covering two heat-tolerant lines and their offspring.
- Genomic selection at scale: US dairy herds routinely genotype heifers at roughly six months of age, combining SNP-chip evaluation with sexed and beef semen to raise genetic merit without any editing.
European Union
The EU proper still applies its pre-2001 GMO framework to gene-edited farm animals, while the UK has moved fastest among European jurisdictions with a dedicated precision-breeding regime and an FDA-adjacent commercial approval.
UK Precision Breeding Act, EU GMO-directive gap, swine disease-resistance R&D#
- Genus plc / PIC PRRS-resistant pig program: a CD163-exon deletion that blocks the PRRS virus’s cell-entry point; approved by the FDA on April 30, 2025, and by Health Canada and the CFIA on January 23, 2026.
- UK Precision Breeding Act (2023): enacted for plants first, with secondary legislation for precision-bred animals still pending as of 2026.
- EU Directive 2001/18 gap: the EU-27 continues to regulate gene-edited farm animals under its original GMO directive, with no dedicated animal precision-breeding pathway yet in force.
China
China’s activity sits at the research stage: university groups are publishing CRISPR-edited livestock embryo work, while the national biosafety framework has not yet opened a commercial-approval pathway for gene-edited farm animals.
CRISPR dairy-cattle heat tolerance, MARA biosafety review, cloning-scale infrastructure#
- Inner Mongolia Agricultural University PRLR/SCNT program: CRISPR-Cas9 editing of a 20–150 bp region of the bovine PRLR gene, combined with somatic cell nuclear transfer, to study heat-stress resilience in dairy cow embryos.
- MARA biosafety review track: gene-edited animal research is evaluated case-by-case; unlike the US and Canada there is no standing commercial-approval pathway yet for gene-edited livestock products.
- Large-scale cloning infrastructure: China’s existing industrial-scale cattle-cloning capacity is an adjacent production base that gene-edited lines could eventually multiply through, once a commercial pathway opens.
6 · Money: tenders & grants
| Grant | Enhancing the competitiveness of organic crop breeding: focus on intercropping adapted varieties European Commission · EU | Sep 22, 2027 341 days |
| Grant | Microbiome for terrestrial livestock sustainability and health within a One Health approach European Commission · EU | Sep 23, 2027 342 days |
| Grant | First in Human and Early Stage Clinical Trials of Novel Investigational Drugs or Neuromodulatory Device-based … National Institutes of Health · United States | Oct 15, 2027 364 days |
| Grant | NSF Scholarships in Science, Technology, Engineering, and Mathematics Program U.S. National Science Foundation · United States | Mar 2, 2027 137 days |
| Grant | Pioneering Aerospace Capabilities, Engineering and Research (PACER) Air Force -- Research Lab · United States | May 10, 2043 6050 days |
7 · Tech stack & innovations
The stack pairs targeted gene editing with population-scale genomic evaluation.
- CRISPR-Cas9 intentional genomic alterations (CRISPR-Cas9 IGAs):
- edits replicate alleles that already occur naturally in some breeds rather than inserting foreign DNA.
- case: the FDA classified the Acceligen PRLR edit as low-risk specifically because it mirrors the natural short-hair allele found in Criollo-derived cattle.
- Somatic cell nuclear transfer (Somatic Cell Nuclear Transfer):
- clones an edited donor cell’s nucleus into an enucleated oocyte to derive founder gene-edited embryos.
- case: SKUAST-Kashmir needed roughly 400 embryo transfers over six years to confirm a single successfully edited lamb, illustrating SCNT’s low efficiency ceiling.
- SNP-chip genomic selection (SNP-Chip Genomic Selection):
- genome-wide marker genotyping estimates breeding values months before an animal’s own performance data exists.
- case: US dairy heifers are genotyped at roughly six months of age on average, ahead of any breeding decision.
Sources 5 · 0 independent · 5 producer sites
Producers' own sites 5
- Acceligen producer checked 2026-06-09 · link not kept
- Genus plc producer checked 2026-02-09 · link not kept
- Semex producer checked 2026-07-03 · link not kept
- Skuast kashmir producer checked 2026-06-12 · link not kept
- Imau producer checked 2025-11-25 · link not kept